Traian Sulea
32Patents
4h-index
46Co-inventors
59Inventor score
Filing activity: Mar 19, 2008 → Nov 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8658135B2 | Antagonists of ligands and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US8318135B2 | Antagonist of ligands and uses thereof | Physics | 18 | Active |
| US8734760B2 | Antagonists of ligands and uses thereof | Physics | 14 | Active |
| US8937163B2 | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof | Chemistry; Metallurgy | 5 | Active |
| US8574548B2 | Antagonists of ligands and uses thereof | Physics | 4 | Active |
| US8987417B2 | Covalently dimerized bivalent binding agents | Physics | 4 | Active |
| US9393302B2 | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof | Chemistry; Metallurgy | 2 | Active |
| US9828426B2 | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof | Chemistry; Metallurgy | 2 | Active |
| US8802826B2 | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume | Chemistry; Metallurgy | 2 | Active |
| US10906973B2 | Antibody variants transmigrating the blood-brain barrier and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10112998B2 | Insulin-like growth factor 1 receptor-specific antibodies and uses thereof | Physics | 1 | Active |
| US11091523B2 | Engineered TGF-β monomers and their use for inhibiting TGF-β signaling | Chemistry; Metallurgy | 1 | Active |
| US10738115B2 | Humanized antibodies transmigrating the blood-brain barrier and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10106614B2 | Insulin-like growth factor 1 receptor-specific antibodies and uses thereof | Physics | 1 | Active |
| US10100117B2 | Insulin-like growth factor 1 receptor-specific antibodies and uses thereof | Physics | 1 | Active |
| US9493562B2 | Anti-Siglec-15 antibodies | Chemistry; Metallurgy | 1 | Active |
| US12421308B2 | Anti-G-CSF antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10538575B2 | Soluble IGF receptor Fc fusion proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11945858B2 | Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications | Chemistry; Metallurgy | 0 | Active |
| US11866481B2 | TGF-β-receptor ectodomain fusion molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12084510B2 | Antibodies selective for cells presenting EGFR at high density | Chemistry; Metallurgy | 0 | Active |
| US11359010B2 | Humanized anti-S100A9 antibody and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10570211B2 | Antibodies selective for cells presenting EGFR at high density | Chemistry; Metallurgy | 0 | Active |
| US9512211B2 | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume | Chemistry; Metallurgy | 0 | Active |
| US9855291B2 | Anti-kidney associated antigen 1 (KAAG1) antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.